Literature DB >> 29875587

Human leukocyte antigen-A*24:02-B*40:247-C*03:04-DRB1*16:02, a deduced probable human leukocyte antigen haplotype associated with a low-incidence human leukocyte antigen allele B*40:247 in Taiwanese individuals: A case analysis.

Kuo-Liang Yang1,2, Zheng-Zhong Zheng3, Li-Yun Lin4.   

Abstract

OBJECTIVE: HLA-B*40:247 is a low incidence allele in the HLA-B locus. The aim of this study is to confirm the ethnicity of B*40:247 and its deduced probable HLA- associated haplotype in Taiwanese individuals.
MATERIALS AND METHODS: A total of 2,329 unrelated Taiwanese individuals and 66,212 unrelated mainland Chinese individuals were tested for HLA using a sequence-based typing method. We confirmed the low incidence allele B*40:247 in Taiwanese. Polymerase chain reaction was performed to amplify exons 2, 3 and 4 of the HLA-A and HLA-B loci and exon 2 of the HLA-DRB1 locus using group-specific primer sets. The amplicons were sequenced in both directions with the *BigDye Terminator Cycle Sequencing Ready Reaction Kit according to the manufacturer's protocols.
RESULTS: The DNA sequence of B*40:247 is identical to B*40:01:01 in exons 2, 3 and 4 except for residue 853, where G of B*40:01:01 is changed to A in B*40:247 (codon 261, GTA->ATA). The nucleotide replacement causes a one amino acid change at codon 261 where V (valine) of B*40:01:01 is replaced by I (isoleucine) in B*40:247. We deduced the probable HLA haplotype associated with B*40:247 in Taiwanese to be HLA-A*24:02-B*40:247-C*03:04-DRB1*16:02.
CONCLUSION: Information on the ethnicity and distribution of B*40:247 and its deduced probable HLA haplotype in association with the low incidence allele is of value for HLA testing laboratories for reference purposes and can help bone marrow donor registries find compatible donors for patients with this uncommon HLA allele.

Entities:  

Keywords:  HLA; Haplotype; Sequence-based typing; Taiwanese; Transplantation

Year:  2018        PMID: 29875587      PMCID: PMC5968747          DOI: 10.4103/tcmj.tcmj_19_18

Source DB:  PubMed          Journal:  Ci Ji Yi Xue Za Zhi


INTRODUCTION

New human leukocyte antigen (HLA) alleles continue to be discovered, and the recognition of HLA low-incidence alleles has enriched our understanding of the complexity of the HLA system. The HLA genes are characterized by their extreme allelic polymorphism as well as their variations and diversity in different ethnic groups and racial populations. The genes encoding the HLA alleles are located in the major histocompatibility complex Class I and II regions. HLA molecules have been definitely defined as transplant antigens and have a strong relevance to tissue transplantation. Their molecular similarity in donors and recipients is being considered a predictive factor for graft survival and graft versus host disease [1]. It is imperative to precisely characterize any unknown and low-incidence alleles encountered during routine HLA typing procedures. To provide successfully, comprehensive unrelated bone marrow hematopoietic stem cell donor searches for patients in need of hematopoietic stem cell transplantation, persistent effort is needed to resolve unidentified, ambiguous, and low-incidence alleles to offer better HLA matching and donor selection. HLA-B*40:247, a rare frequency allele (http://www.allelefrequencies.net), was first reported to the IMGT/HLA database in 2013 (IMGT/HLA Ass No: HLA09904) without information on the B*40:247-associated HLA haplotype and ethnic origin of the source individual [2]. In this report, we confirm the ethnicity of B*40:247 and identify the deduced plausible HLA haplotype in association with B*40:247 based on the HLA typing of Taiwanese individuals and the donor submitted to the IMGT/HLA database [2].

MATERIALS AND METHODS

A total of 2329 unrelated Taiwanese individuals and 66,212 unrelated mainland Chinese participants were tested for B*40:247 in this study. Peripheral whole blood samples from donors with Taiwanese ethnicity and individuals with mainland Chinese ethnicity were collected in acid citrate dextrose (ACD) anticoagulant. Formal written consent was signed by the donors before blood collection. The ACD whole blood samples were stored at −80°C until use. Genomic DNA was extracted using the QIAamp DNA Blood Mini kit according to the manufacturer's instructions (Qiagen, Hilden, Germany). The DNA material was subjected to HLA genotyping for the HLA-A, HLA-B, HLA-C, and HLA-DRB1 loci using a commercial polymerase chain reaction-sequencing-based typing kit (TBG, Medigen Biotechnology, Taipei, Taiwan). The amplicons were sequenced in both directions with the *BigDye Terminator Cycle Sequencing Ready Reaction kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's protocols.

RESULTS

In a total of 2329 randomized unrelated Taiwanese individuals tested, two unrelated Taiwanese Hakka individuals with B*40:247 were identified. This means that the frequency of B*40:247 in the Taiwanese population is approximately 0.086%. However, in a total of 66,212 randomized mainland Chinese blood donors studied, no individual with B*40:247 was found. We confirmed that the DNA sequence of B*40:247 is identical to B*40:01:01 in exons 2, 3, and 4 except for a one nucleotide substitution at residue 853 (G->A, codon 261 GTA->ATA) in exon 4 [Figure 1]. The nucleotide substitution results a one amino acid replacement at amino acid position 261 where V (valine) of B*40:01:01 is replaced by I (isoleucine) in B*40:247 [Figure 2]. The extended HLA-A, HLA-B, HLA-C, and HLA-DRB1 typing of the donors with B*40:247 in this study was A*02:06, A*24:02, B*15:25, B*40:247, C*03:04, C*04:03, DRB1*12:02, and DRB1*16:02, and A*02:03, A*24:02, B*38:02, B*40:247, C*03:04, C*07:02, and DRB1*16:02. Based on the common HLA-A, HLA-B, HLA-C, and HLA-DRB1 alleles of these two donors and the donor with HLA typing (A*11:01, A*24:02, B*40:01, B*40:247, C*03:04, C*07:02, DRB1*12:01, and DRB1*16:02) reported to the IMGT/HLA database [23], we deduced the probable HLA haplotype in association with B*40:247 in Taiwanese to be A*24:02-B*40:247-C*03:04-DRB1*16:02 [Table 1]. Our observation strongly indicates Taiwanese ethnicity of the rare HLA-B allele, B*40:247.
Figure 1

The DNA sequence of B*40:247 is identical to B*40:01:01 in exons 2, 3, and 4 except for a one nucleotide substitution at residue 853 (shaded) where G of B*40:01:01 is replaced by A in B*40:247 (codon 261; GTA->ATA; underlined) in exon 4 (only exon 4 is shown here). Dashes indicate nucleotide identity with B*40:01:01

Figure 2

The nucleotide substitution of B*40:01:01 results in a one amino acid replacement at amino acid position 261 (shaded) where V (valine) of B*40:01:01 is replaced by I (isoleucine) in B*40:247. Dashes indicate amino acid identity with B*40:01:01

Table 1

The deduced plausible HLA haplotype in association with B*40:247

Donor IDHLA-A, -B, -C, -DRB1 typing of donorsDeduced probable HLA haplotype in association with B*40:247
Donor 1A*02:06, A*24:02, B*15:25, B*40:247, C*03:04, C*04:03, DRB1*12:02 DRB1*16:02A*24:02-B*40:247-C*03:04-DRB1*16:02
Donor 2A*02:03, A*24:02, B*38:02, B*40:247, C*03:04, C*07:02, DRB1*16:02A*24:02-B*40:247-C*03:04-DRB1*16:02
Donor 3aA*11:01, A*24:02, B*40:01, B*40:247, C*03:04, C*07:02, DRB1*12:01 DRB1*16:02A*24:02-B*40:247-C*03:04-DRB1*16:02

The plausible HLA haplotype in association with B*40:247 is deduced based on HLA typing of the two Taiwanese individuals we observed and the donora submitted to the IMGT/HLA Database

The DNA sequence of B*40:247 is identical to B*40:01:01 in exons 2, 3, and 4 except for a one nucleotide substitution at residue 853 (shaded) where G of B*40:01:01 is replaced by A in B*40:247 (codon 261; GTA->ATA; underlined) in exon 4 (only exon 4 is shown here). Dashes indicate nucleotide identity with B*40:01:01 The nucleotide substitution of B*40:01:01 results in a one amino acid replacement at amino acid position 261 (shaded) where V (valine) of B*40:01:01 is replaced by I (isoleucine) in B*40:247. Dashes indicate amino acid identity with B*40:01:01 The deduced plausible HLA haplotype in association with B*40:247 The plausible HLA haplotype in association with B*40:247 is deduced based on HLA typing of the two Taiwanese individuals we observed and the donora submitted to the IMGT/HLA Database

DISCUSSION

We confirmed the DNA sequence and amino acid sequence of the low-frequency allele HLA-B*40:247 [2]. The DNA sequence of B*40:247 is identical to B*40:01:01 in exons 2, 3, and 4 except for a one nucleotide substitution at residue 853. The nucleotide substitution results in a one amino acid replacement at amino acid position 261 in B*40:247. Whether the mutation of B*40:247 in exon 4 has any impact on antigen presentation, and immune regulation functions of its protein molecule are unclear. This warrants the future study. B*40:247 was initially discovered in a Taiwanese individual (Genbank Accession Number KF208638; IMGT/HLA Database HWS10018882) [2] without knowledge of the probable HLA haplotype in association with the allele. In this study, we ascertained the ethnicity of B*40:247 and proposed the deduced probable B*40:247-associated HLA haplotype to be A*24:02-B*40:247-C*03:04-DRB1*16:02 based on the HLA-A, HLA-B, HLA-C, and HLA-DRB1 alleles shared in common by our randomized unrelated donors and the donor reported to the IMGT/HLA Database [Table 1]. Although we found two Hakka Taiwanese individuals carrying B*40:247, we cannot be certain B*40:247 is restricted to Hakka Taiwanese, pending further investigation. Nevertheless, we propose that the deduced probable B*40:247-associated HLA haplotype is most likely restricted to Taiwanese since B*40:247 has only been found in the Taiwanese population but not in the mainland Chinese population. Furthermore, our search on the Allele Frequency Net (http://www.allelefrequencies.net) failed to find B*40:247 in other populations. In addition, the lack of B*40:247 in the mainland Chinese population is supported by Zhou et al.[4], who found no individual with B*40:247 in a total of 169,995 volunteer donors tested from the China Bone Marrow Donor Registry Program. Information on the ethnicity of B*40:247 and its linked HLA haplotype can be employed in the anthropological investigation of races. In addition, bone marrow donor registries can allocate appropriate unrelated stem cell donors for patients with B*40:247. In addition, knowing the nucleotide and amino acid variation between B*40:247 and the prevalently observed B*40:01:01 allele may be helpful when selecting a minor HLA mismatched unrelated bone marrow stem cell donor for a patient with the rare B*40:247 allele. It is worth mentioning that the most direct and classic method of determining HLA haplotypes is through a family study if test materials from a number of key family members are available. Alternatively, a population study may be employed if a sufficient number of unrelated donors are available [5]. However, the haplotypes deduced through population investigation are considered to be likely or most probable. In this study, because of the lack of availability of necessary test materials from the families of the individuals with B*40:247, we opted to determine the haplotypes by looking at the HLA alleles carried in common by unrelated donors with the same alleles of interest. By the same token, if determination of plausible HLA-associated haplotypes is for rare or low-frequency HLA alleles, the alleles shared in common by unrelated individuals may be employed to deduce the associated probable haplotypes [678910111213]. The frequency of B*40:247 in Taiwanese is extremely low at approximately 0.086%. Therefore, we think that the deduced probable B*40:247-associated HLA haplotype in Taiwanese in this study is accurate. The number of known HLA alleles is increasing with the recent development of DNA-based molecular typing technology. There is a high level of HLA diversity among ethnic groups and knowledge of this diversity is important. Matching of bone marrow stem cell donors relies on the accuracy of HLA typing results. This is dependent on the resolution of unknown, ambiguous, and low-incidence genes in the HLA system.

Declaration of patient consent

The authors certify that all patients provided appropriate patient consent forms. In the form, all patients gave consent for their images and other clinical information to be reported in the journal. All patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  12 in total

Review 1.  HLA DNA typing and transplantation.

Authors:  H A Erlich; G Opelz; J Hansen
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

2.  Discovery of a novel HLA-B*51 variant, B*51:112, in a Taiwanese bone marrow donor and identification of the plausible HLA haplotype in association with B*51:112.

Authors:  K L Yang; S K Lee; P Y Lin
Journal:  Int J Immunogenet       Date:  2012-03-16       Impact factor: 1.466

3.  Recognition of HLA-A*24:137 allele in a Taiwanese unrelated bone marrow stem cell donor and the plausible HLA haplotype associated with A*24:137.

Authors:  K L Yang; S K Lee; R H Kao; C L Lin; P Y Lin
Journal:  Int J Immunogenet       Date:  2012-06-06       Impact factor: 1.466

4.  Identification of the novel HLA allele, HLA-B*40:159, in a Taiwanese hematopoietic stem cell donor and the probable HLA haplotype in an association with B*40:159.

Authors:  K L Yang; S K Lee; P Y Lin
Journal:  Int J Immunogenet       Date:  2012-05-31       Impact factor: 1.466

5.  HLA-B*40:247, a novel HLA-B*40 variant, identified by sequence-based typing in a Taiwanese individual.

Authors:  C L Chang; C Y Lin
Journal:  HLA       Date:  2017-04-05       Impact factor: 4.513

6.  Oriental HLA-A*11:90 detected in a Taiwanese cord blood sample and the haplotype in association with A*11:90 allele.

Authors:  K L Yang; S K Lee; C C Lin; S Jiang; H M Chiu; S Lin; Y C Chen; Y F Jian; S Y Yang; Y B Yang; S B Chen; M H Shyr; C L Lin; P Y Lin
Journal:  Int J Immunogenet       Date:  2011-08-02       Impact factor: 1.466

7.  Discovery of the novel HLA-DRB1*03:77 allele in a Taiwanese unrelated hematopoietic stem cell donor by a sequence-based typing method and identification of the probable HLA haplotype in association with DRB1*03:77.

Authors:  K L Yang; S K Lee; R H Kao; C L Lin; P Y Lin
Journal:  Int J Immunogenet       Date:  2012-04-10       Impact factor: 1.466

8.  Discovery of the novel HLA-DRB1*16:16 allele in a Taiwanese unrelated bone marrow stem cell donor by a sequence-based typing method and the probable haplotype associated with DRB1*16:16.

Authors:  K L Yang; S K Lee; R H Kao; C L Lin; P Y Lin
Journal:  Int J Immunogenet       Date:  2012-04-10       Impact factor: 1.466

9.  High-resolution human leukocyte antigen (HLA) haplotypes and linkage disequilibrium of HLA-B and -C and HLA-DRB1 and -DQB1 alleles in a Taiwanese population.

Authors:  Kuo-Liang Yang; Shee-Ping Chen; Ming-Huang Shyr; Py-Yu Lin
Journal:  Hum Immunol       Date:  2009-02-21       Impact factor: 2.850

10.  The IMGT/HLA database.

Authors:  James Robinson; Kavita Mistry; Hamish McWilliam; Rodrigo Lopez; Peter Parham; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2010-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.